The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children

Critical Care

Volumn 14, Issue 3, 2010, Pages

  Mankhambo, Limangeni A ^a   Banda, Daniel L ^a   Jeffers, Graham ^c   White, Sarah A ^a   Balmer, Paul ^b   Nkhoma, Standwell ^a   Phiri, Happy ^a   Molyneux, Elizabeth M ^a   Hart, C Anthony ^c   Molyneux, Malcolm E ^a   Heyderman, Robert S ^a   Carrol, Enitan D ^a,c  

^a UNIVERSITY OF MALAWI   (Malawi)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTIBIOTIC AGENT; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN; ANGIOGENIC PROTEIN; ANGIOPOIETIN; BIOLOGICAL MARKER;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BLOOD SAMPLING; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INVASIVE PNEUMOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SURVIVOR; TREATMENT OUTCOME; BLOOD; HOSPITALIZATION; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE;

ANGIOGENIC PROTEINS; ANGIOPOIETINS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALAWI; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77952432851     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9025     Document Type: Article

References (50)

1. Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, Cherian T. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009, 374:903-911. 10.1016/S0140-6736(09)61203-4, 19748399.
2. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902. 10.1016/S0140-6736(09)61204-6, 19748398.
3. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004, 8:462-468. 10.1186/cc2894, 1065042, 15566617.
4. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109:656-663. 10.1161/01.CIR.0000114522.38265.61, 14734516.
5. Luo TH, Wang Y, Lu ZM, Zhou H, Xue XC, Bi JW, Ma LY, Fang GE. The change and effect of endothelial progenitor cells in pig with multiple organ dysfunction syndromes. Crit Care 2009, 13:R118. 10.1186/cc7968, 2750166, 19604356.
6. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001, 276:7614-7620. 10.1074/jbc.M009705200, 11108718.
7. Lucerna M, Mechtcheriakova D, Kadl A, Schabbauer G, Schafer R, Gruber F, Koshelnick Y, Muller HD, Issbrucker K, Clauss M, Binder BR, Hofer E. NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. J Biol Chem 2003, 278:11433-11440. 10.1074/jbc.M204937200, 12427750.
8. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 1994, 125:917-928. 10.1083/jcb.125.4.917, 2120083, 7514607.
9. Thommen R, Humar R, Misevic G, Pepper MS, Hahn AW, John M, Battegay EJ. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J Cell Biochem 1997, 64:403-413. 10.1002/(SICI)1097-4644(19970301)64:3<403::AID-JCB7>3.0.CO;2-Z, 9057098.
10. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004, 2:2096-2102. 10.1111/j.1538-7836.2004.01009.x, 15613012.
11. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 1997, 151:1775-1784. 1858363, 9403728.
12. Maier JA, Morelli D, Menard S, Colnaghi MI, Balsari A. Tumor-necrosis-factor-induced fibroblast growth factor-1 acts as a survival factor in a transformed endothelial cell line. Am J Pathol 1996, 149:945-952. 1865157, 8780398.
13. Huang CC, Liu CC, Wang ST, Chang YC, Yang HB, Yeh TF. Basic fibroblast growth factor in experimental and clinical bacterial meningitis. Pediatr Res 1999, 45:120-127. 10.1203/00006450-199901000-00020, 9890619.
14. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005, 118:771-780. 10.1242/jcs.01653, 15687104.
15. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Circ Res 2000, 86:24-29.
16. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 2000, 275:9102-9105. 10.1074/jbc.275.13.9102, 10734041.
17. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002, 99:11205-11210. 10.1073/pnas.172161899, 123234, 12163646.
18. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12:R147. 10.1186/cc7130, 2646310, 19025590.
19. Giuliano JS, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS. Admission angiopoietin levels in children with septic shock. Shock 2007, 28:650-654. 2754128, 18092380.
20. Phelps ED, Updike DL, Bullen EC, Grammas P, Howard EW. Transcriptional and posttranscriptional regulation of angiopoietin-2 expression mediated by IGF and PDGF in vascular smooth muscle cells. Am J Physiol Cell Physiol 2006, 290:C352-361. 10.1152/ajpcell.00050.2005, 16176970.
21. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007, 35:199-206. 10.1097/01.CCM.0000251640.77679.D7, 17110873.
22. Kumpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009, 13:R64. 10.1186/cc7866, 2717419, 19416526.
23. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009, 31:348-353. 10.1097/SHK.0b013e318188bd06, 18791490.
24. van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005, 23:35-38. 10.1097/01.shk.0000150728.91155.41, 15614129.
25. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006, 203:1447-1458. 10.1084/jem.20060375, 2118329, 16702604.
26. Brueckmann M, Hoffmann U, Engelhardt C, Lang S, Fukudome K, Haase KK, Liebe V, Kaden JJ, Putensen C, Borggrefe M, Huhle G. Prognostic value of platelet-derived growth factor in patients with severe sepsis. Growth Factors 2007, 25:15-24. 10.1080/08977190701272784, 17454146.
27. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008, 29:452-457. 10.1097/SHK.0b013e31815072c1, 18598002.
28. Karlsson S, Pettila V, Tenhunen J, Lund V, Hovilehto S, Ruokonen E. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth Analg 2008, 106:1820-1826. 10.1213/ane.0b013e31816a643f, 18499616.
29. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005, 24:508-512. 10.1097/01.shk.0000190827.36406.6e, 16317379.
30. Choi SH, Park EY, Jung HL, Shim JW, Kim DS, Park MS, Shim JY. Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion. J Korean Med Sci 2006, 21:608-613. 10.3346/jkms.2006.21.4.608, 2729879, 16891801.
31. Bermejo-Martin JF, Garcia-Arevalo MC, De Lejarazu RO, Ardura J, Eiros JM, Alonso A, Matias V, Pino M, Bernardo D, Arranz E, Blanco-Quiros A. Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur Cytokine Netw 2007, 18:162-167.
32. Payton A, Payne D, Mankhambo LA, Banda DL, Hart CA, Ollier WE, Carrol ED. Nitric oxide synthase 2A (NOS2A) polymorphisms are not associated with invasive pneumococcal disease. BMC Med Genet 2009, 10:28. 10.1186/1471-2350-10-28, 2666671, 19309520.
33. Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, Balmer P, Banda DL, Jeffers G, White SA, Molyneux EM, Molyneux ME, Smyth RL, Hart CA. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 2007, 26:416-422. 10.1097/01.inf.0000260253.22994.61, 2810843, 17468652.
34. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989, 71:441-459.
35. Carrol ED, Mankhambo LA, Balmer P, Nkhoma S, Banda DL, Guiver M, Jeffers G, Makwana N, Molyneux EM, Molyneux ME, Smyth RL, Hart CA. Chemokine responses are increased in HIV-infected Malawian children with invasive pneumococcal disease. J Acquir Immune Defic Syndr 2007, 44:443-450. 10.1097/QAI.0b013e31802f8390, 2811313, 17195767.
36. Trzeciak S, Cinel I, Phillip Dellinger R, Shapiro NI, Arnold RC, Parrillo JE, Hollenberg SM. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008, 15:399-413. 10.1111/j.1553-2712.2008.00109.x, 2727641, 18439194.
37. Minhas N, Xue M, Fukudome K, Jackson CJ. Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function. FASEB J 2010, 24:873-881. 10.1096/fj.09-134445, 19858095.
38. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
39. Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, Sundin DP, Giroir B. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007, 369:836-843. 10.1016/S0140-6736(07)60411-5, 17350452.
40. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA 2008, 105:17097-17102. 10.1073/pnas.0805782105, 2575222, 18957536.
41. Conroy AL, Lafferty EI, Lovegrove FE, Krudsood S, Tangpukdee N, Liles WC, Kain KC. Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J 2009, 8:295. 10.1186/1475-2875-8-295, 2806378, 20003529.
42. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, Krudsood S, Looareesuwan S, John CC, Liles WC, Kain KC. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS ONE 2009, 4:e4912. 10.1371/journal.pone.0004912, 2657207, 19300530.
43. Molyneux E, Walsh A, Phiri A, Molyneux M. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97. Trop Med Int Health 1998, 3:610-618.
44. Planche T, Agbenyega T, Bedu-Addo G, Ansong D, Owusu-Ofori A, Micah F, Anakwa C, Asafo-Agyei E, Hutson A, Stacpoole PW, Krishna S. A prospective comparison of malaria with other severe diseases in African children: prognosis and optimization of management. Clin Infect Dis 2003, 37:890-897. 10.1086/377536, 13130399.
45. Becchi C, Pillozzi S, Fabbri LP, Al Malyan M, Cacciapuoti C, Della Bella C, Nucera M, Masselli M, Boncinelli S, Arcangeli A, Amedei A. The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. Int J Immunopathol Pharmacol 2008, 21:697-705.
46. Carrol ED, Thomson AP, Mobbs KJ, Hart CA. The role of RANTES in meningococcal disease. J Infect Dis 2000, 182:363-366. 10.1086/315680, 10882626.
47. Moller AS, Bjerre A, Brusletto B, Joo GB, Brandtzaeg P, Kierulf P. Chemokine patterns in meningococcal disease. J Infect Dis 2005, 191:768-775. 10.1086/427514, 15688294.
48. van der Flier M, Stockhammer G, Vonk GJ, Nikkels PG, van Diemen-Steenvoorde RA, van der Vlist GJ, Rupert SW, Schmutzhard E, Gunsilius E, Gastl G, Hoepelman AI, Kimpen JL, Geelen SP. Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis 2001, 183:149-153. 10.1086/317643, 11106541.
49. Coenjaerts FE, van der Flier M, Mwinzi PN, Brouwer AE, Scharringa J, Chaka WS, Aarts M, Rajanuwong A, van de Vijver DA, Harrison TS, Hoepelman AI. Intrathecal production and secretion of vascular endothelial growth factor during cryptococcal meningitis. J Infect Dis 2004, 190:1310-1317. 10.1086/423849, 15346343.
50. van Der Flier M, Coenjaerts F, Kimpen JL, Hoepelman AM, Geelen SP. Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils. Infect Immun 2000, 68:4792-4794. 10.1128/IAI.68.8.4792-4794.2000, 98440, 10899891.